Screener
AngioDynamics ANGO Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
| Line item | Year ended May 31, 2026 | Year ended May 31, 2025 | Year ended May 31, 2024 |
|---|---|---|---|
| Additions to placement and evaluation units | (3,368) | (5,714) | (5,015) |
| Proceeds from sale of assets | — | — | 134,500 |
| Acquisition of intangibles | — | — | (3,250) |
| Net cash (used in) provided by investing activities | (5,949) | (10,178) | 123,717 |
| Cash flows from financing activities: | |||
| Repayment of long-term debt | — | — | (50,000) |
| Deferred financing costs on long-term debt | — | (680) | — |
| Principal payments on financing arrangement | (375) | (148) | — |
Item 15. Exhibits, Financial Statement Schedules.
FAQ
- What is AngioDynamics's investing cash flow?
- AngioDynamics (ANGO) reported investing cash flow of -$1.27M in Q1 2026.
- How has AngioDynamics's investing cash flow changed year-over-year?
- AngioDynamics's investing cash flow increased by 51.6% year-over-year, from -$2.62M to -$1.27M.
- What is the long-term trend for AngioDynamics's investing cash flow?
- Over 3 years (2022 to 2026), AngioDynamics's investing cash flow has grown at a -32.5% compound annual growth rate (CAGR), from -$19.31M to -$5.95M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about AngioDynamics's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude